#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15592	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2620	730.0	0	.	n	.	0	C1450T	SNP	1450	1450	C	1848	1848	T	979	T,G,C,A	974,3,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15592	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2620	730.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1582	1582	C	950	C,T	949,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26146	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4022	811.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1904	1904	A	1033	A,T,C	1031,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26146	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4022	811.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2538	2538	C	955	C,G	953,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26146	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4022	811.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2612	2612	A	856	A,C	855,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26146	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4022	811.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3164	3164	C	960	C,T,A	957,1,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2410	folP	855	855	100.0	folP.l15.c4.ctg.1	1994	150.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1266	1268	AGC	244;242;242	A;G,T;C	244;241,1;242	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5732	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3929	182.2	1	SNP	p	S91F	1	.	.	271	273	TTC	864	866	TTC	228;229;229	T;T;C	228;229;229	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5732	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3929	182.2	1	SNP	p	D95G	1	.	.	283	285	GGC	876	878	GGC	235;234;237	G;G;C	235;234;237	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5732	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3929	182.2	1	SNP	p	G95N	0	.	.	283	285	GGC	876	878	GGC	235;234;237	G;G;C	235;234;237	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	2306	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1873	153.8	1	SNP	p	G45D	0	.	.	133	135	GGC	784	786	GGC	275;273;268	G;G;C	275;273;268	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1192	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1714	86.9	0	.	n	.	0	A197.	DEL	197	197	A	863	863	A	234	A,T,C	231,2,1	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	5342	parC	2304	2304	99.83	parC.l6.c4.ctg.1	3367	197.8	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1821	1823	GCA	275;275;277	G,A;C;A	274,1;275;277	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	5342	parC	2304	2304	99.83	parC.l6.c4.ctg.1	3367	197.8	1	SNP	p	D86N	0	.	.	256	258	GAC	774	776	GAC	245;248;248	G;A;C	245;248;248	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	5342	parC	2304	2304	99.83	parC.l6.c4.ctg.1	3367	197.8	1	SNP	p	R87I	0	.	.	259	261	CGT	777	779	CGT	248;248;250	C,G;G,A,C;T	247,1;246,1,1;250	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	5342	parC	2304	2304	99.83	parC.l6.c4.ctg.1	3367	197.8	1	SNP	p	R87W	0	.	.	259	261	CGT	777	779	CGT	248;248;250	C,G;G,A,C;T	247,1;246,1,1;250	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	5342	parC	2304	2304	99.83	parC.l6.c4.ctg.1	3367	197.8	1	SNP	p	S87R	1	.	.	259	261	CGT	777	779	CGT	248;248;250	C,G;G,A,C;T	247,1;246,1,1;250	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	5342	parC	2304	2304	99.83	parC.l6.c4.ctg.1	3367	197.8	1	SNP	p	S88P	0	.	.	262	264	TCC	780	782	TCC	250;250;249	T;C;C	250;250;249	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4602	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3261	176.1	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1736	1738	TGC	240;241;248	T,G;G;C	239,1;241;248	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4602	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3261	176.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1946	1948	GGC	264;263;259	G;G,C;C	264;262,1;259	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	4162	penA	1749	1749	99.94	penA.l15.c30.ctg.1	3008	172.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1586	1588	GCA	247;248;250	G;C;A	247;248;250	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4162	penA	1749	1749	99.94	penA.l15.c30.ctg.1	3008	172.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1589	1591	ATC	250;250;252	A,T,C;T;C	248,1,1;250;252	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4162	penA	1749	1749	99.94	penA.l15.c30.ctg.1	3008	172.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1601	1603	GTG	252;256;257	G;T,G;G,C	252;255,1;256,1	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4162	penA	1749	1749	99.94	penA.l15.c30.ctg.1	3008	172.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1601	1603	GTG	252;256;257	G;T,G;G,C	252;255,1;256,1	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4162	penA	1749	1749	99.94	penA.l15.c30.ctg.1	3008	172.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2105	2107	ACC	260;257;259	A;C,G;C	260;256,1;259	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4162	penA	1749	1749	99.94	penA.l15.c30.ctg.1	3008	172.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2159	2161	GCG	223;223;220	G;C;G	223;223;220	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4162	penA	1749	1749	99.94	penA.l15.c30.ctg.1	3008	172.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2159	2161	GCG	223;223;220	G;C;G	223;223;220	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4162	penA	1749	1749	99.94	penA.l15.c30.ctg.1	3008	172.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2282	2284	GGC	226;230;231	G;G,A;C,A	226;229,1;230,1	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4162	penA	1749	1749	99.94	penA.l15.c30.ctg.1	3008	172.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2291	2293	GGC	237;239;241	G,C;G;C	236,1;239;241	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4162	penA	1749	1749	99.94	penA.l15.c30.ctg.1	3008	172.8	1	SNP	p	P552S	1	.	.	1654	1656	TCG	2309	2311	TCG	246;247;247	T,G,C;C;G,A	241,3,2;247;246,1	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5532	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3652	189.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1849	1851	CCG	234;235;233	C;C;G	234;235;233	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2934	porA	1146	1146	99.56	porA.l15.c4.ctg.1	2395	153.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	905	905	C	214	C	214	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	290	porB1a	984	226	90.27	porB1a.l15.c30.ctg.2	369	26.3	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	26;28;30	T;T;A	26;28;30	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	290	porB1a	984	226	90.27	porB1a.l15.c30.ctg.2	369	26.3	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	59;59;59	C;A;T	59;59;59	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	290	porB1a	984	226	90.27	porB1a.l15.c30.ctg.2	369	26.3	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	59;59;59	A;G,A;T	59;58,1;59	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	290	porB1a	984	226	90.27	porB1a.l15.c30.ctg.2	369	26.3	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	59;59;59	T;A;C	59;59;59	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	290	porB1a	984	226	90.27	porB1a.l15.c30.ctg.2	369	26.3	0	.	p	.	0	R307A	NONSYN	919	921	AGA	161	163	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	290	porB1a	984	226	90.27	porB1a.l15.c30.ctg.2	369	26.3	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	290	porB1a	984	226	90.27	porB1a.l15.c30.ctg.2	369	26.3	0	.	p	.	0	E312D	NONSYN	934	936	GAA	176	178	GAC	2;2;2	G;A;C	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	290	porB1a	984	226	90.27	porB1a.l15.c30.ctg.2	369	26.3	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	2;2;2	A;T;C	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	290	porB1a	984	226	90.27	porB1a.l15.c30.ctg.2	369	26.3	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	2;2;2	T;C;G	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	290	porB1a	984	226	90.27	porB1a.l15.c30.ctg.2	369	26.3	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	290	porB1a	984	226	90.27	porB1a.l15.c30.ctg.2	369	26.3	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	2;2;2	A;G;C	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	290	porB1a	984	226	90.27	porB1a.l15.c30.ctg.2	369	26.3	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	290	porB1a	984	226	90.27	porB1a.l15.c30.ctg.2	369	26.3	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	2;2;2	G;T;T	2;2;2	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2972	porB1b	1047	1047	98.95	porB1b.l6.c30.ctg.1	2046	180.9	0	.	p	.	0	N38E	NONSYN	112	114	AAT	614	616	GAA	274;273;268	G,T;A;A	273,1;273;268	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2972	porB1b	1047	1047	98.95	porB1b.l6.c30.ctg.1	2046	180.9	0	.	p	.	0	N134D	NONSYN	400	402	AAT	902	904	GAT	256;261;261	G;A;T	256;261;261	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2972	porB1b	1047	1047	98.95	porB1b.l6.c30.ctg.1	2046	180.9	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1025	1027	TCA	273;272;271	T;C;A	273;272;271	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2972	porB1b	1047	1047	98.95	porB1b.l6.c30.ctg.1	2046	180.9	0	.	p	.	0	F215T	NONSYN	643	645	TTT	1145	1147	ACT	243;244;244	A,T;C;T,A	241,2;244;243,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2972	porB1b	1047	1047	98.95	porB1b.l6.c30.ctg.1	2046	180.9	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1154	1156	GTG	247;248;245	G;T,C;G	247;247,1;245	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2972	porB1b	1047	1047	98.95	porB1b.l6.c30.ctg.1	2046	180.9	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1484	1486	GCA	227;227;232	G,A;C;A	226,1;227;232	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2972	porB1b	1047	1047	98.95	porB1b.l6.c30.ctg.1	2046	180.9	1	SNP	p	G120K	1	.	.	358	360	AAG	860	862	AAG	254;255;258	A,G,C;A;G	252,1,1;255;258	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2972	porB1b	1047	1047	98.95	porB1b.l6.c30.ctg.1	2046	180.9	1	SNP	p	A121D	1	.	.	361	363	GAC	863	865	GAC	258;264;261	G;A,C;C	258;263,1;261	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2972	porB1b	1047	1047	98.95	porB1b.l6.c30.ctg.1	2046	180.9	1	SNP	p	D121N	0	.	.	361	363	GAC	863	865	GAC	258;264;261	G;A,C;C	258;263,1;261	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	256	porB3	990	200	91.5	porB3.l15.c30.ctg.1	205	37.2	0	.	p	.	0	V260L	NONSYN	778	780	GTA	14	16	TTA	26;28;30	T;T;A	26;28;30	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	256	porB3	990	200	91.5	porB3.l15.c30.ctg.1	205	37.2	0	.	p	.	0	D275H	NONSYN	823	825	GAT	59	61	CAT	60;60;60	C;A;T	60;60;60	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	256	porB3	990	200	91.5	porB3.l15.c30.ctg.1	205	37.2	0	.	p	.	0	D276S	NONSYN	826	828	GAT	62	64	AGT	60;60;60	A;G,A;T	60;59,1;60	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	256	porB3	990	200	91.5	porB3.l15.c30.ctg.1	205	37.2	0	.	p	.	0	K278D	NONSYN	832	834	AAA	68	70	GAC	60;60;60	G;A;C	60;60;60	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	256	porB3	990	200	91.5	porB3.l15.c30.ctg.1	205	37.2	0	.	p	.	0	R279Y	NONSYN	835	837	CGC	71	73	TAC	60;60;60	T;A;C	60;60;60	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	256	porB3	990	200	91.5	porB3.l15.c30.ctg.1	205	37.2	0	.	p	.	0	E309A	NONSYN	925	927	GAA	161	163	GCA	1;1;1	G;C;A	1;1;1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	256	porB3	990	200	91.5	porB3.l15.c30.ctg.1	205	37.2	0	.	p	.	0	E313A	NONSYN	937	939	GAA	173	175	GCA	1;1;1	G;C;A	1;1;1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	256	porB3	990	200	91.5	porB3.l15.c30.ctg.1	205	37.2	0	.	p	.	0	N314D	NONSYN	940	942	AAC	176	178	GAC	1;1;1	G;A;C	1;1;1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	256	porB3	990	200	91.5	porB3.l15.c30.ctg.1	205	37.2	0	.	p	.	0	A318S	NONSYN	952	954	GCG	188	190	TCG	1;1;1	T;C;G	1;1;1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	256	porB3	990	200	91.5	porB3.l15.c30.ctg.1	205	37.2	0	.	p	.	0	G321S	NONSYN	961	963	GGC	197	199	AGC	1;1;1	A;G;C	1;1;1	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10004	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5420	230.5	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2265	2267	AAT	261;261;261	A;A;T	261;261;261	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1406	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1444	121.2	1	SNP	p	V57M	1	.	.	169	171	ATG	699	701	ATG	225;227;228	A,G;T;G	223,1;227;228	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
